Can this agreement be signed electronically?

Yes. Electronic signatures are legally valid under the ESIGN Act (15 U.S.C. ch. 96) and UETA where adopted; ensure the transaction does not fall under statutory exceptions such as wills or certain court filings.

Is an eSignature acceptable for HIPAA-covered agreements?

Yes, provided the eSignature platform supports required safeguards and parties execute a Business Associate Agreement when PHI is processed or stored, and policies meet HIPAA administrative, technical, and physical safeguards.

Do I need IRB approval before signing the contract?

IRB approval is generally required before initiating participant enrollment. Contracts may be signed earlier, but researchers should not enroll subjects until IRB authorization and any required regulatory approvals are in place.

What governing law should we choose?

Select the state law that aligns with parties' commercial expectations and venue preferences. ESIGN preempts inconsistent state law for interstate transactions, but state UETA rules may apply for intrastate issues.

How long must I keep the executed agreement?

Retention depends on context: IRS records are generally 3 years (IRC §6501(a)), HIPAA-related records six years (45 CFR §164.530(j)), and institutions often retain contracts seven years post-termination.

Can remote notarization be used for execution?

Remote Online Notarization is permitted in most states with specific identity-proofing and audio-video recording requirements; verify state notary rules and retention obligations before relying on RON.

Electronic Signature
Templates
Healthcare
Healthcare Clinical Research Agreement

Healthcare Clinical Research Agreement

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE CLINICAL RESEARCH AGREEMENT

Parties and Study Identification

Sponsor:

Sponsor Address

Research Institution:

Institution Address

Principal Investigator:

Research Site: Effective Date:

Study Title:

Protocol Number: IND/IDE (if applicable):

Recitals and Scope

This Clinical Research Agreement (the "Agreement") sets forth the terms and conditions under which Sponsor will engage Institution and Principal Investigator to conduct the Study identified above. The parties agree that the Study will be conducted in accordance with the Protocol, applicable law, Good Clinical Practice, and Institutional policies.

Brief Description of Study

Regulatory and Ethics Approval

Institution will obtain and maintain approval from the Institutional Review Board (IRB) or Ethics Committee prior to initiation of any Study activities involving human subjects. IRB Approval Date: . Any material amendments to the Protocol require prior IRB approval.

Principal Investigator and Site Responsibilities

Principal Investigator will conduct the Study in accordance with the Protocol and applicable regulations, ensure informed consent is properly obtained and documented, supervise site staff, maintain accurate study records, comply with monitoring and audit requests, and promptly report Serious Adverse Events as required below.

Enrollment Target (total subjects)

Informed Consent and Subject Protection

Institution and Principal Investigator will ensure each subject provides written informed consent using a consent form approved by the IRB prior to any Study procedures. Consent must include disclosure of risks, benefits, alternative treatments, and subject rights to withdraw without penalty.

Consent Form Version / Date

Compensation and Payments

Sponsor shall pay Institution for performance of Study activities in accordance with the Payment Schedule. Payments are contingent on submission of required invoices and deliverables and on Sponsor's acceptance of properly documented services.

Total Budget Amount Payment Schedule and Billing Instructions

Confidentiality; Data Ownership and Publication

Confidential Information disclosed by a party in connection with the Study is proprietary and shall be used solely to perform obligations under this Agreement. Sponsor retains ownership of study data and results generated by Sponsor; Institution retains rights to Site‑specific records required by law. Prior to public disclosure of Study results, Investigator shall provide Sponsor with written notice of any proposed publication and allow Sponsor a reasonable review period.

Publication Notice Period (days)

Data Privacy and HIPAA Compliance

Each party shall comply with applicable privacy laws, including the protection of Personal Health Information (PHI). Sponsor may request access to PHI only as necessary to fulfill Sponsor obligations and will limit use and disclosure accordingly.

Authorization for Use/Disclosure of PHI - Expiration Date

Consent required for PHI use must be obtained from each subject when required by law; where required, Institution will secure a HIPAA-compliant authorization or create a limited dataset under a data use agreement.

HIPAA Compliance Acknowledgment

Institution and Sponsor acknowledge obligations to maintain privacy and security of PHI and to execute a Business Associate Agreement if required.

Adverse Events, Safety Reporting and Insurance

Investigator will report Serious Adverse Events (SAEs) to Sponsor and the IRB in accordance with the Protocol and regulatory requirements. Sponsor will notify Investigator of any safety information that may affect subject welfare.

SAE Reporting Requirement (hours) Insurance Requirements (limits and carrier)

Indemnification

Each party shall indemnify, defend and hold harmless the other party from claims arising from its own negligent acts, willful misconduct, or breach of this Agreement, subject to the limitations and procedures set forth in this section.

Record Retention, Audit and Monitoring

Institution will retain study records for the greater of applicable regulatory requirement or years and permit Sponsor and regulatory authorities to audit study records in a manner that protects patient privacy.

Term, Termination and Remedies

This Agreement begins on the Effective Date and continues until completion of the Study or earlier termination. Either party may terminate for material breach following written notice and a day cure period. Termination shall not affect rights accrued prior to termination.

Notices and Governing Law

Notices To Sponsor Notices To Institution

This Agreement is governed by the laws of: without regard to conflicts of law principles.

Miscellaneous Provisions

Amendments to this Agreement must be in writing and signed by authorized representatives of both parties. Neither party may assign this Agreement without the prior written consent of the other, except to a successor in interest to substantially all of its business.

Sponsor

Printed Name:

By:

Date:

Title:

Institution

Printed Name:

By:

Date:

Title:

What the Healthcare Clinical Research Agreement Is

A Healthcare Clinical Research Agreement is a written contract that sets the legal terms for a clinical study between sponsors, clinical sites, investigators, and vendors. It defines study scope, responsibilities, data ownership, confidentiality, indemnification, payment, regulatory compliance, reporting obligations, and intellectual property. The agreement governs participant recruitment, informed consent processes, data handling consistent with HIPAA, and requirements for Institutional Review Board approval. Well-drafted agreements reduce disputes, clarify liability for adverse events, and create a record of obligations for audits, inspections, and contract management.

Why a Clear Agreement Matters for Clinical Research

A precise Healthcare Clinical Research Agreement allocates risk, ensures regulatory compliance, protects patient data, and documents financial and operational responsibilities between sponsor and site. It supports auditability and helps meet IRB and agency expectations.

Who Typically Prepares and Signs This Agreement

Several parties commonly prepare, review, and execute these agreements before study start-up and enrollment begins.

Study Sponsors or Sponsors' Legal Teams: Draft commercial terms, funding, indemnity, and IP provisions; negotiate with sites and CROs.
Clinical Sites and Principal Investigators: Review operational obligations, patient protection clauses, and payment schedules prior to signing.
Contract Research Organizations (CROs) and Vendors: Sign for outsourced services, monitoring, data management, and laboratory work.

Final execution usually requires authorized signatories from each organization and confirmation of IRB and regulatory prerequisites.

Authorized Signers and Their Roles

Principal Investigator

The Principal Investigator often approves site-specific operational commitments and confirms IRB compliance; they are not always the contractual signatory but must authorize site performance and participant safety procedures.

Sponsor Signatory

An authorized sponsor representative or corporate officer typically signs to bind the sponsor to funding, indemnity, and data ownership obligations; legal counsel often reviews commercial and regulatory terms before execution.

Core Sections to Include in the Agreement

A professional Healthcare Clinical Research Agreement organizes responsibilities, protections, and compliance measures so each party understands expectations for study conduct and data handling.

Study Scope

Clear description of protocol, study sites, participant population, enrollment targets, and deliverables so operational duties are unambiguous and measurable throughout the trial.

Payment Terms

Detailed schedule for study payments, reimbursable expenses, invoicing cadence, and payment conditions to prevent disputes about sponsor/site compensation.

Data Use & Ownership

Allocation of ownership, licensing rights, data access, publication rights, de-identified data handling, and requirements for clinical data transfer agreements.

Patient Privacy

HIPAA and privacy commitments, required Business Associate Agreement (BAA) when PHI is shared, and controls for data security and permitted disclosures.

Indemnity & Liability

Mechanics of indemnification, liability caps, insurance requirements, and which party pays legal costs in third-party claims or patient injury cases.

Termination & Cure

Termination triggers, cure periods, wind-down responsibilities, and obligations for data return, retention, and ongoing monitoring after study close.

Essential Compliance and Security Elements

HIPAA: BAA required

Data Encryption: TLS 1.2/1.3 in transit

Data at Rest: AES-256 encryption

Audit Trail: Timestamped logs

Access Controls: Role-based permissions

Retention Policy: Document lifecycle defined

Step-by-Step: Completing the Agreement

Follow this sequence to prepare, review, and execute the Healthcare Clinical Research Agreement with minimal friction.

01

Drafting: Sponsor prepares initial template and inserts protocol-specific terms.
02

Site Review: Site and PI review operational and budget sections for feasibility.
03

Legal Review: Each party's counsel confirms compliance and risk allocation.
04

Execution: Authorized signatories sign, and documents are dated and archived.

Setting Up an Online Execution Workflow

Configure fields, signer order, and authentication to align with IRB timing, sponsor review, and institutional policies before sending for signature.

Field	Configuration
Signature Order	Sponsor first \| Site second
Authentication	Email + SMS code \| Optional KBA
Required Attachments	IRB approval letter \| Protocol
Retention	Audit trail kept \| PDF export

Where to Send and File the Executed Agreement

Route the fully executed agreement to the right institutional offices and external parties to ensure compliance and proper recordkeeping.

Site Legal Office: Store executed PDF in contract repository and notify research administration.
Sponsor Contracting: Sponsor retains master copy and confirms obligations with finance.
IRB Office: Attach executed agreement to the IRB file if required by the IRB.
Clinical Trial Registry: Ensure required registry entries cite contract dates as applicable.

Digital Signing and eSubmission Requirements

Choose an eSignature platform that supports required authentication, audit trails, and HIPAA protections before eSubmission.

Authentication: Email + SMS code
Audit Trail: Full event log
HIPAA Support: BAA available

Ensure the platform stores tamper-evident PDFs, supports export to institutional repositories, and meets any 21 CFR Part 11 or BAA obligations when electronic records are used in regulated submissions.

Key Risks and Penalties to Watch

HIPAA Violations: Civil and criminal liability

Regulatory Noncompliance: FDA or IRB sanctions possible

Contract Breach: Monetary damages and injunctions

Data Loss: Reputational and legal exposure

Delayed Start: Missed enrollment windows

Incorrect Signatory: Agreement may be unenforceable

Common Preparation Mistakes

Failing to confirm IRB approval before executing, which delays participant enrollment and may invalidate early activities.
Using inconsistent legal entity names or contractor IDs, creating reconciliation problems and delaying invoice processing and payment.
Omitting explicit data handling or BAA language when PHI is involved, increasing regulatory and breach exposure.
Not aligning payment milestones with deliverables, leading to disputes over invoicing, auditing, and sponsor reimbursements.

Real-World Use Cases

Two concise examples illustrate how the agreement functions in common study scenarios.

Academic Hospital Trial

A university hospital used a standardized agreement to speed site activation and reduce negotiation time by consolidating appendices.

Enrollment targets were clearly tied to milestone payments.
The standardized approach simplified IRB submission, centralized legal review, and shortened time-to-first-patient by eliminating repetitive clause-by-clause negotiation across departments.

Multi-Site CRO Study

A CRO negotiated master terms with regional sites to handle monitoring and data management consistently.

Central billing terms simplified invoicing across sites.
Centralized contracting and uniform data handling provisions reduced administrative overhead, ensured consistent monitoring practices, and improved sponsor visibility across geographic locations.

eSignature Vendor Comparison for Clinical Research Agreements

Compare common eSignature features and starting prices to evaluate platforms that support HIPAA, audit trails, and high-volume clinical contracting.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day trial	Varies	Varies	Varies	Varies
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

Frequently Asked Questions

Answers to common legal, technical, and operational questions about executing Healthcare Clinical Research Agreements electronically.

Need help? Contact support

Can this agreement be signed electronically?
Yes. Electronic signatures are legally valid under the ESIGN Act (15 U.S.C. ch. 96) and UETA where adopted; ensure the transaction does not fall under statutory exceptions such as wills or certain court filings.
Is an eSignature acceptable for HIPAA-covered agreements?
Yes, provided the eSignature platform supports required safeguards and parties execute a Business Associate Agreement when PHI is processed or stored, and policies meet HIPAA administrative, technical, and physical safeguards.
Do I need IRB approval before signing the contract?
IRB approval is generally required before initiating participant enrollment. Contracts may be signed earlier, but researchers should not enroll subjects until IRB authorization and any required regulatory approvals are in place.
What governing law should we choose?
Select the state law that aligns with parties' commercial expectations and venue preferences. ESIGN preempts inconsistent state law for interstate transactions, but state UETA rules may apply for intrastate issues.
How long must I keep the executed agreement?
Retention depends on context: IRS records are generally 3 years (IRC §6501(a)), HIPAA-related records six years (45 CFR §164.530(j)), and institutions often retain contracts seven years post-termination.
Can remote notarization be used for execution?
Remote Online Notarization is permitted in most states with specific identity-proofing and audio-video recording requirements; verify state notary rules and retention obligations before relying on RON.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now